G Berger – författare

Keine ausfuhrliche Beschreibung fur "e;Biovitrokeram Implantatwerkstoffe"e; verfugbar.

My dear children,you have been gone now for many years.How can one say goodbye to people without whomone does not know how to live.For all these years the only way to keep in touch with youwas by letter but always without any answer or response.You are now 18 years old, adults and responsible for yourself.These letters may remind you of your father who loves you.

Irvin M. Cushner, MD, MPH It is both remarkable and, at the same time, a sign of this era of rapid change that one can refer back to the "infancy" of a field which has existed for barely more than a decade. Yet, one now reads of the "maturing" of the family planning and abortion fields, both of which were incorporated into our society and integrated into our health care system within the past ten years. Indeed, in the very year that this book is being prepared, we note the tenth anniversaries of several significant events of 1970: 1) the enactment of Title X of the Public Health Service Act, establishing a Federal program in family planning; 2) the first issuance by a major health-related organization (the APHA) of a policy statement advocating repeal of all abortion laws; and 3) the enactment, by New York State, of an abortion law whose only restric­ tion was that it be performed by a licensed physician and the subse­ quent action, the first by any local health department (New York City), to assure both its implementation and its quality. They were, indeed, eventful days. These three events seemed to presage a then-unprecedented acceptance of fertility regulation as a right and as a needed service.

Irvin M. Cushner, MD, MPH It is both remarkable and, at the same time, a sign of this era of rapid change that one can refer back to the "infancy" of a field which has existed for barely more than a decade. Yet, one now reads of the "maturing" of the family planning and abortion fields, both of which were incorporated into our society and integrated into our health care system within the past ten years. Indeed, in the very year that this book is being prepared, we note the tenth anniversaries of several significant events of 1970: 1) the enactment of Title X of the Public Health Service Act, establishing a Federal program in family planning; 2) the first issuance by a major health-related organization (the APHA) of a policy statement advocating repeal of all abortion laws; and 3) the enactment, by New York State, of an abortion law whose only restric­ tion was that it be performed by a licensed physician and the subse­ quent action, the first by any local health department (New York City), to assure both its implementation and its quality. They were, indeed, eventful days. These three events seemed to presage a then-unprecedented acceptance of fertility regulation as a right and as a needed service.

It is clear today that several prostaglandins play an important role in the regulation of many of the physiological events of the reproductive organs in the human. Both naturally occurring prostaglandins and their analogues are used routinely in many countries to ripen the cervix and induce labour at term as well as to dilate the cervix and to terminate pregnancy. Prostaglandin biosynthesis inhibitors are widely used in the treatment of primary dysmenorrhoea. The editors have aimed at an accurate, thorough, yet easily under­ standable review of the status in 1986 of medical knowledge regarding both the physiological importance and the clinical use of prostaglan­ dins and their inhibitors in obstetrics and gynaecology. I believe this book will be of value for all clinicians concerned with reproductive health. The list of authors guarantees an authoritative and up-to-date review of this active field. SUNE BERGSTROM Karolinska Institutet, Stockholm, Sweden Table Examples of clinical use of natural prostaglandins and some prostaglandin analogues Indications Prostaglandin Route of administration Manufacturer Dilatation of the cervix prior 15-methyl-PGF • Intramuscular Upjohn, USA 2 to vacuum aspiration 16-phenoxy-PGE methyl sulphonylamide Intramuscular Schering AG, West Germany 2 16,16-dimethyl-PGE methyl ester 1 Vaginal ONO, Japan; May & Baker, UK Second trimester abortion Intra -amniotic Upjohn, USA; ONO, Japan PGF 20 Upjohn, USA PGE Vaginal 2 Upjohn, USA 15-methyl-PGF 2.